Lipoproteins: When size really matters

J. Bruce German, Jennifer T. Smilowitz, Angela M. Zivkovic

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The field of nanoscience is extending the applications of physics, chemistry and biology into previously unapproached infinitesimal length scales. Understanding the behavior and manipulating the positions and properties of single atoms and molecules hold great potential to improve areas of science as disparate as medicine and computation, and communication and orbiting satellites. Yet, in the race to develop novel, previously unavailable nanoparticles, there is an opportunity for scientists in this field to digress and to apply their growing understanding of nanoscience and the tools of nanotechnology to one of the most pressing problems in all of human biology-diseases related to lipoproteins. Although not appreciated outside the field of lipoprotein biology, variations in the compositions, structures and properties of these nanoscale-sized, blood-borne particles are responsible for most of the variations in health, morbidity and mortality in the Western world. If the lipoproteins could be understood at the nanometer length scale with precise details of their structures and functions, scientists could understand a wide range of perplexing physiological processes and also address the dysfunctions in normal lipoprotein biology that lead to such diseases as hypercholesterolemia, heart disease, stroke and neurodegenerative diseases. Furthermore, if the capabilities of nanoscience to assemble and manipulate nanometer-sized particles could be recruited to studies of lipoproteins, these biological particles would provide a new dimension to therapeutic agents, and these natural particles could be designed to carry out many specialized beneficial tasks.

Original languageEnglish (US)
Pages (from-to)171-183
Number of pages13
JournalCurrent Opinion in Colloid and Interface Science
Volume11
Issue number2-3
DOIs
StatePublished - Jun 2006

Fingerprint

lipoproteins
Lipoproteins
Nanoscience
biology
Neurodegenerative diseases
communication satellites
heart diseases
mortality
pressing
nanotechnology
strokes
medicine
Nanotechnology
Medicine
health
blood
Blood
Physics
Health
Satellites

Keywords

  • Lipoproteins
  • Nanoparticles
  • Nanoscience
  • Nanotechnology

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Surfaces and Interfaces

Cite this

Lipoproteins : When size really matters. / German, J. Bruce; Smilowitz, Jennifer T.; Zivkovic, Angela M.

In: Current Opinion in Colloid and Interface Science, Vol. 11, No. 2-3, 06.2006, p. 171-183.

Research output: Contribution to journalArticle

German, J. Bruce ; Smilowitz, Jennifer T. ; Zivkovic, Angela M. / Lipoproteins : When size really matters. In: Current Opinion in Colloid and Interface Science. 2006 ; Vol. 11, No. 2-3. pp. 171-183.
@article{b89341beb0e94c73802dc837dac3b239,
title = "Lipoproteins: When size really matters",
abstract = "The field of nanoscience is extending the applications of physics, chemistry and biology into previously unapproached infinitesimal length scales. Understanding the behavior and manipulating the positions and properties of single atoms and molecules hold great potential to improve areas of science as disparate as medicine and computation, and communication and orbiting satellites. Yet, in the race to develop novel, previously unavailable nanoparticles, there is an opportunity for scientists in this field to digress and to apply their growing understanding of nanoscience and the tools of nanotechnology to one of the most pressing problems in all of human biology-diseases related to lipoproteins. Although not appreciated outside the field of lipoprotein biology, variations in the compositions, structures and properties of these nanoscale-sized, blood-borne particles are responsible for most of the variations in health, morbidity and mortality in the Western world. If the lipoproteins could be understood at the nanometer length scale with precise details of their structures and functions, scientists could understand a wide range of perplexing physiological processes and also address the dysfunctions in normal lipoprotein biology that lead to such diseases as hypercholesterolemia, heart disease, stroke and neurodegenerative diseases. Furthermore, if the capabilities of nanoscience to assemble and manipulate nanometer-sized particles could be recruited to studies of lipoproteins, these biological particles would provide a new dimension to therapeutic agents, and these natural particles could be designed to carry out many specialized beneficial tasks.",
keywords = "Lipoproteins, Nanoparticles, Nanoscience, Nanotechnology",
author = "German, {J. Bruce} and Smilowitz, {Jennifer T.} and Zivkovic, {Angela M.}",
year = "2006",
month = "6",
doi = "10.1016/j.cocis.2005.11.006",
language = "English (US)",
volume = "11",
pages = "171--183",
journal = "Current Opinion in Colloid and Interface Science",
issn = "1359-0294",
publisher = "Elsevier BV",
number = "2-3",

}

TY - JOUR

T1 - Lipoproteins

T2 - When size really matters

AU - German, J. Bruce

AU - Smilowitz, Jennifer T.

AU - Zivkovic, Angela M.

PY - 2006/6

Y1 - 2006/6

N2 - The field of nanoscience is extending the applications of physics, chemistry and biology into previously unapproached infinitesimal length scales. Understanding the behavior and manipulating the positions and properties of single atoms and molecules hold great potential to improve areas of science as disparate as medicine and computation, and communication and orbiting satellites. Yet, in the race to develop novel, previously unavailable nanoparticles, there is an opportunity for scientists in this field to digress and to apply their growing understanding of nanoscience and the tools of nanotechnology to one of the most pressing problems in all of human biology-diseases related to lipoproteins. Although not appreciated outside the field of lipoprotein biology, variations in the compositions, structures and properties of these nanoscale-sized, blood-borne particles are responsible for most of the variations in health, morbidity and mortality in the Western world. If the lipoproteins could be understood at the nanometer length scale with precise details of their structures and functions, scientists could understand a wide range of perplexing physiological processes and also address the dysfunctions in normal lipoprotein biology that lead to such diseases as hypercholesterolemia, heart disease, stroke and neurodegenerative diseases. Furthermore, if the capabilities of nanoscience to assemble and manipulate nanometer-sized particles could be recruited to studies of lipoproteins, these biological particles would provide a new dimension to therapeutic agents, and these natural particles could be designed to carry out many specialized beneficial tasks.

AB - The field of nanoscience is extending the applications of physics, chemistry and biology into previously unapproached infinitesimal length scales. Understanding the behavior and manipulating the positions and properties of single atoms and molecules hold great potential to improve areas of science as disparate as medicine and computation, and communication and orbiting satellites. Yet, in the race to develop novel, previously unavailable nanoparticles, there is an opportunity for scientists in this field to digress and to apply their growing understanding of nanoscience and the tools of nanotechnology to one of the most pressing problems in all of human biology-diseases related to lipoproteins. Although not appreciated outside the field of lipoprotein biology, variations in the compositions, structures and properties of these nanoscale-sized, blood-borne particles are responsible for most of the variations in health, morbidity and mortality in the Western world. If the lipoproteins could be understood at the nanometer length scale with precise details of their structures and functions, scientists could understand a wide range of perplexing physiological processes and also address the dysfunctions in normal lipoprotein biology that lead to such diseases as hypercholesterolemia, heart disease, stroke and neurodegenerative diseases. Furthermore, if the capabilities of nanoscience to assemble and manipulate nanometer-sized particles could be recruited to studies of lipoproteins, these biological particles would provide a new dimension to therapeutic agents, and these natural particles could be designed to carry out many specialized beneficial tasks.

KW - Lipoproteins

KW - Nanoparticles

KW - Nanoscience

KW - Nanotechnology

UR - http://www.scopus.com/inward/record.url?scp=33744971832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744971832&partnerID=8YFLogxK

U2 - 10.1016/j.cocis.2005.11.006

DO - 10.1016/j.cocis.2005.11.006

M3 - Article

AN - SCOPUS:33744971832

VL - 11

SP - 171

EP - 183

JO - Current Opinion in Colloid and Interface Science

JF - Current Opinion in Colloid and Interface Science

SN - 1359-0294

IS - 2-3

ER -